1
|
Bron AM, Mariet AS, Benzenine E, Arnould L, Daien V, Korobelnik JF, Quantin C, Creuzot-Garcher C. Trends in operating room-based glaucoma procedures in France from 2005 to 2014: a nationwide study. Br J Ophthalmol 2017; 101:1500-1504. [PMID: 28292777 DOI: 10.1136/bjophthalmol-2016-309946] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2016] [Revised: 12/23/2016] [Accepted: 02/12/2017] [Indexed: 12/18/2022]
Abstract
PURPOSE To report the trends in operating room-based glaucoma procedures from 2005 to 2014 in France. METHODS We identified operating room-based glaucoma procedures (trabeculectomies, deep sclerectomies, aqueous shunts and ciliary body destructions) performed in France from 2005 to 2014 by means of billing codes from a national database. The annual rates and incidence of these procedures per 100 000 inhabitants were analysed globally and in three age groups: 0-14 years, 15-59 years and over 60 years. RESULTS The annual rate of trabeculectomies decreased slightly during the study period, while the rate for other surgical techniques (deep sclerectomies, aqueous drainage procedures and ciliary body destructions) increased. The overall rate of glaucoma surgeries was higher in areas with populations of African descent than in areas predominantly composed of Caucasian populations: 1.60 (95% CI 1.51 to 1.70, p<0.0001). CONCLUSIONS Trabeculectomy was the most commonly performed operating room-based glaucoma procedure in France from 2005 to 2014. Other modalities such as deep sclerectomies, aqueous drainage procedures and ciliary body destruction gained greater acceptance among French ophthalmologists during this 10-year period.
Collapse
Affiliation(s)
- Alain M Bron
- Eye and Nutrition Research Group, Centre des Sciences du Goût et de l'Alimentation, CNRS, INRA, Université Bourgogne Franche-Comté, Dijon, France.,Ophthalmology Department, Dijon University Hospital, Dijon, France
| | - Anne-Sophie Mariet
- Dijon University Hospital, Dijon, France.,Biostatistics and Bioinformatics (DIM), Dijon, France.,Bourgogne Franche-Comté University, Dijon, France.,INSERM, CIC 1432, Dijon, France.,Clinical Epidemiology/Clinical Trials Unit, Dijon University Hospital, Clinical Investigation Center, Dijon, France.,INSERM UMR 1181 Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases (B2PHI), Bourgogne Franche-Comté University, Dijon, France
| | - Eric Benzenine
- Dijon University Hospital, Dijon, France.,Biostatistics and Bioinformatics (DIM), Dijon, France.,Bourgogne Franche-Comté University, Dijon, France
| | - Louis Arnould
- Eye and Nutrition Research Group, Centre des Sciences du Goût et de l'Alimentation, CNRS, INRA, Université Bourgogne Franche-Comté, Dijon, France.,Ophthalmology Department, Dijon University Hospital, Dijon, France
| | - Vincent Daien
- Ophthalmology Department, Montpellier University Hospital, Montpellier, France
| | - Jean François Korobelnik
- Ophthalmology Department, Bordeaux University Hospital, Bordeaux, France.,Inserm, U1219-Bordeaux Population Health Research Center, Bordeaux, France
| | - Catherine Quantin
- Dijon University Hospital, Dijon, France.,Biostatistics and Bioinformatics (DIM), Dijon, France.,Bourgogne Franche-Comté University, Dijon, France.,INSERM, CIC 1432, Dijon, France.,Clinical Epidemiology/Clinical Trials Unit, Dijon University Hospital, Clinical Investigation Center, Dijon, France.,INSERM UMR 1181 Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases (B2PHI), Bourgogne Franche-Comté University, Dijon, France
| | - Catherine Creuzot-Garcher
- Eye and Nutrition Research Group, Centre des Sciences du Goût et de l'Alimentation, CNRS, INRA, Université Bourgogne Franche-Comté, Dijon, France.,Ophthalmology Department, Dijon University Hospital, Dijon, France
| |
Collapse
|
2
|
Innovative approaches to glaucoma management of Boston keratoprosthesis type 1. CURRENT OPHTHALMOLOGY REPORTS 2016; 4:147-153. [PMID: 28529825 DOI: 10.1007/s40135-016-0102-3] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Glaucoma remains a prevalent disorder and visual limiting factor after Boston keratoprosthesis type 1 implantation. Patients with glaucoma have worse initial and late visual acuity outcomes after otherwise successful keratoprosthesis implantation. Management of glaucoma in the setting of a keratoprosthesis is challenging because of relatively rapid progression and an inability to accurately measure intraocular pressure (IOP). In addition, there are no standard guidelines for glaucoma surveillance and monitoring after keratoprosthesis surgery. This report provides a review of the current literature and offers innovative strategies that will overcome the challenges in managing glaucoma in the setting of a Boston keratoprosthesis type 1 implant. The topics that will be discussed in this section include alternative methods for IOP measurement, rationales and surgical techniques for a pars plana tube placement for glaucoma drainage device, effective medical and laser treatment, the risk for IOP elevations after YAG laser, and practical guides to glaucoma surveillance and monitoring.
Collapse
|
3
|
Thomas RE, Crichton A, Thomas BC. Antimetabolites in cataract surgery to prevent failure of a previous trabeculectomy. Cochrane Database Syst Rev 2014; 2014:CD010627. [PMID: 25066789 PMCID: PMC10576260 DOI: 10.1002/14651858.cd010627.pub2] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
BACKGROUND Patients having cataract surgery have often earlier undergone a trabeculectomy for glaucoma. However, cataract surgery may be associated with failure of the previous glaucoma surgery and antimetabolites may be used with cataract surgery to prevent such failure. There is no systematic review on whether antimetabolites with cataract surgery prevent failure of a previous trabeculectomy. OBJECTIVES To assess the effects of antimetabolites with cataract surgery on functioning of a previous trabeculectomy. SEARCH METHODS We searched CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) (2014, Issue 5), Ovid MEDLINE, Ovid MEDLINE In-Process and Other Non-Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946 to June 2014), EMBASE (January 1980 to June 2014), Latin American and Caribbean Health Sciences Literature Database (LILACS) (January 1982 to June 2014), the metaRegister of Controlled Trials (mRCT) (www.controlled-trials.com), ClinicalTrials.gov (www.clinicaltrials.gov) and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/search/en). We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 10 June 2014. We also searched the Science Citation Index database (July 2013) and reference lists of potentially relevant studies. SELECTION CRITERIA Randomised controlled trials (RCTs) of antimetabolites with cataract surgery in people with a functioning trabeculectomy. DATA COLLECTION AND ANALYSIS Two review authors independently reviewed the titles and abstracts from the electronic searches. Two review authors independently assessed relevant full-text articles and entered data. MAIN RESULTS We identified no RCTs to test the effectiveness of antimetabolites with cataract surgery in individuals with the intention of preventing failure of a previous trabeculectomy. AUTHORS' CONCLUSIONS There are no RCTs of antimetabolites with cataract surgery in people with a functioning trabeculectomy. Appropriately powered RCTs are needed of antimetabolites during cataract surgery in patients with a functioning trabeculectomy.
Collapse
Affiliation(s)
- Roger E Thomas
- University of CalgaryDepartment of Family Medicine, Faculty of MedicineUCMC#1707‐1632 14th AvenueCalgaryABCanadaT2M 1N7
| | - Andrew Crichton
- University of Calgary Medical SchoolOphthalmology, Department of Surgery#102, 49 Richard Way SWCalgaryABCanadaT3E 7M8
| | | | | |
Collapse
|